Table 4. . Longitudinal follow-up of the patients in the prospective study: disease location.
Category | Number of patients in each category | ||||
---|---|---|---|---|---|
Disease location† | None known | Cervical | Pulmonary | Skeletal | Hepatic |
Baseline status‡ | 29 | 5 | 4 | 0 | 0 |
1-year follow-up | 28 | 5 | 5 | 0 | 0 |
2-year follow-up | 28 | 4 | 4 | 0 | 0 |
3-year follow-up | 29 | 3 | 4 | 0 | 1 |
4-year follow-up | 30 | 5 | 4 | 1 | 1 |
5-year follow-up | 6 | 2 | 1 | 0 | 1 |
†n = 38 patients for initial status and years 1–4, n = 9 for fifth year of follow-up, may be more than one disease location per patient.
‡Baseline disease status after initial treatment was assessed based on a combination of surgical pathology, results of postoperative radioiodine scanning and postoperative thyroglobulin measurement at approximately 2 months after surgery.